• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症患者纹状体、丘脑、黑质、边缘系统区域及皮质中的多巴胺D2受体水平。

Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects.

作者信息

Kessler Robert M, Woodward Neil D, Riccardi Patrizia, Li Rui, Ansari M Sib, Anderson Sharlett, Dawant Benoit, Zald David, Meltzer Herbert Y

机构信息

Department of Radiology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.

出版信息

Biol Psychiatry. 2009 Jun 15;65(12):1024-31. doi: 10.1016/j.biopsych.2008.12.029. Epub 2009 Feb 28.

DOI:10.1016/j.biopsych.2008.12.029
PMID:19251247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2951678/
Abstract

BACKGROUND

Studies in schizophrenic patients have reported dopaminergic abnormalities in striatum, substantia nigra, thalamus, anterior cingulate, hippocampus, and cortex that have been related to positive symptoms and cognitive impairments.

METHODS

[(18)F]fallypride positron emission tomography studies were performed in off-medication or never-medicated schizophrenic subjects (n = 11, 6 men, 5 women; mean age of 30.5 +/- 8.0 [SD] years; 4 drug-naive) and age-matched healthy subjects (n = 11, 5 men, 6 women, mean age of 31.6 +/- 9.2 [SD]) to examine dopamine D(2) receptor (DA D(2)r) levels in the caudate, putamen, ventral striatum, medial thalamus, posterior thalamus, substantia nigra, amygdala, temporal cortex, anterior cingulate, and hippocampus.

RESULTS

In schizophrenic subjects, increased DA D(2)r levels were seen in the substantia nigra bilaterally; decreased levels were seen in the left medial thalamus. Correlations of symptoms with ROI data demonstrated a significant correlation of disorganized thinking/nonparanoid delusions with the right temporal cortex ROI (r = .94, p = .0001), which remained significant after correction for multiple comparisons (p < .03). Correlations of symptoms with parametric images of DA D(2)r levels revealed no significant clusters of correlations with negative symptoms but significant clusters of positive correlations of total positive symptoms, delusions and bizarre behavior with the lateral and anterior temporal cortex, and hallucinations with the left ventral striatum.

CONCLUSIONS

The results of this study demonstrate abnormal DA D(2)r-mediated neurotransmission in the substantia nigra consistent with nigral dysfunction in schizophrenia and suggest that both temporal cortical and ventral striatal DA D(2)r mediate positive symptoms.

摘要

背景

对精神分裂症患者的研究报告称,纹状体、黑质、丘脑、前扣带回、海马体和皮质中存在多巴胺能异常,这些异常与阳性症状和认知障碍有关。

方法

对未服药或从未服药的精神分裂症患者(n = 11,6名男性,5名女性;平均年龄30.5±8.0[标准差]岁;4名未用过药)和年龄匹配的健康受试者(n = 11,5名男性,6名女性,平均年龄31.6±9.2[标准差])进行[(18)F]氟哌利多正电子发射断层扫描研究,以检测尾状核、壳核、腹侧纹状体、内侧丘脑、后丘脑、黑质、杏仁核、颞叶皮质、前扣带回和海马体中的多巴胺D(2)受体(DA D(2)r)水平。

结果

在精神分裂症患者中,双侧黑质的DA D(2)r水平升高;左侧内侧丘脑的水平降低。症状与感兴趣区(ROI)数据的相关性表明,思维紊乱/非偏执性妄想与右侧颞叶皮质ROI显著相关(r = 0.94,p = 0.0001),在进行多重比较校正后仍具有显著性(p < 0.03)。症状与DA D(2)r水平参数图像的相关性显示,与阴性症状无显著相关簇,但总阳性症状、妄想和怪异行为与外侧和颞叶前部皮质存在显著正相关簇,幻觉与左侧腹侧纹状体存在显著正相关簇。

结论

本研究结果表明,黑质中存在异常的DA D(2)r介导的神经传递,这与精神分裂症中的黑质功能障碍一致,并提示颞叶皮质和腹侧纹状体的DA D(2)r均介导阳性症状。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee3/2951678/18c5e65ff9fe/nihms121610f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee3/2951678/1f624ab94431/nihms121610f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee3/2951678/018ce862a033/nihms121610f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee3/2951678/f8d6f0b0c53a/nihms121610f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee3/2951678/18c5e65ff9fe/nihms121610f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee3/2951678/1f624ab94431/nihms121610f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee3/2951678/018ce862a033/nihms121610f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee3/2951678/f8d6f0b0c53a/nihms121610f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee3/2951678/18c5e65ff9fe/nihms121610f4.jpg

相似文献

1
Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects.精神分裂症患者纹状体、丘脑、黑质、边缘系统区域及皮质中的多巴胺D2受体水平。
Biol Psychiatry. 2009 Jun 15;65(12):1024-31. doi: 10.1016/j.biopsych.2008.12.029. Epub 2009 Feb 28.
2
Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine.氯氮平和喹硫平对纹状体及纹状体以外多巴胺D2受体的占有率。
Neuropsychopharmacology. 2006 Sep;31(9):1991-2001. doi: 10.1038/sj.npp.1301108. Epub 2006 May 31.
3
Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans.苯丙胺引起的人体纹状体和纹状体以外区域中[18F]法氯必利的取代。
Neuropsychopharmacology. 2006 May;31(5):1016-26. doi: 10.1038/sj.npp.1300916.
4
Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol.奥氮平和氟哌啶醇对纹状体及纹状体以外多巴胺D2/D3受体的占有率。
Neuropsychopharmacology. 2005 Dec;30(12):2283-9. doi: 10.1038/sj.npp.1300836.
5
Nigrostriatal and Mesolimbic D Receptor Expression in Parkinson's Disease Patients with Compulsive Reward-Driven Behaviors.帕金森病患者强迫性奖励驱动行为的黑质纹状体和中脑边缘 D 受体表达。
J Neurosci. 2018 Mar 28;38(13):3230-3239. doi: 10.1523/JNEUROSCI.3082-17.2018. Epub 2018 Feb 26.
6
D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia.精神分裂症患者丘脑和皮质中[F-18]氟哌利多与D2/D3多巴胺受体的结合情况。
Schizophr Res. 2006 Jul;85(1-3):232-44. doi: 10.1016/j.schres.2006.03.042. Epub 2006 May 19.
7
Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study.精神分裂症和抑郁症的中脑多巴胺功能:尸检和正电子发射断层扫描成像研究。
Brain. 2013 Nov;136(Pt 11):3242-51. doi: 10.1093/brain/awt264. Epub 2013 Oct 3.
8
Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride.利用[125I]表哌立登在人死后大脑中鉴定纹状体以外的多巴胺D2受体。
Brain Res. 1993 Apr 23;609(1-2):237-43. doi: 10.1016/0006-8993(93)90878-q.
9
The relationship between excitement symptom severity and extrastriatal dopamine D receptor availability in patients with schizophrenia: a high-resolution PET study with [F]fallypride.精神分裂症患者兴奋症状严重程度与纹状体外多巴胺 D 受体可用性的关系:一项使用 [F]fallypride 的高分辨率 PET 研究。
Eur Arch Psychiatry Clin Neurosci. 2018 Sep;268(6):529-540. doi: 10.1007/s00406-017-0821-y. Epub 2017 Jun 16.
10
Midbrain dopamine D2/3 receptor binding in schizophrenia.精神分裂症中脑多巴胺D2/3受体结合情况
Eur Arch Psychiatry Clin Neurosci. 2006 Sep;256(6):382-7. doi: 10.1007/s00406-006-0649-3. Epub 2006 Jun 16.

引用本文的文献

1
Developing algorithmic psychiatry via multi-level spanning computational models.通过多层次跨尺度计算模型发展算法精神病学。
Cell Rep Med. 2025 May 20;6(5):102094. doi: 10.1016/j.xcrm.2025.102094. Epub 2025 Apr 28.
2
Causal associations between iron levels in subcortical brain regions and psychiatric disorders: a Mendelian randomization study.皮质下脑区铁水平与精神障碍之间的因果关联:一项孟德尔随机化研究
Transl Psychiatry. 2025 Jan 22;15(1):19. doi: 10.1038/s41398-025-03231-8.
3
A neural modeling approach to study mechanisms underlying the heterogeneity of visual spatial frequency sensitivity in schizophrenia.

本文引用的文献

1
Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse.纹状体多巴胺D2受体可用性低与尼古丁依赖的关联类似于在其他滥用药物中所见。
Am J Psychiatry. 2008 Apr;165(4):507-14. doi: 10.1176/appi.ajp.2007.07020352. Epub 2008 Mar 3.
2
Projections from the paraventricular nucleus of the thalamus to the forebrain, with special emphasis on the extended amygdala.从丘脑室旁核向前脑的投射,特别强调扩展杏仁核。
J Comp Neurol. 2008 Jan 10;506(2):263-87. doi: 10.1002/cne.21502.
3
Estimation of baseline dopamine D2 receptor occupancy in striatum and extrastriatal regions in humans with positron emission tomography with [18F] fallypride.
一种神经建模方法,用于研究精神分裂症视觉空间频率敏感性异质性背后的机制。
Schizophrenia (Heidelb). 2024 Jul 16;10(1):63. doi: 10.1038/s41537-024-00480-2.
4
Accentuated Paralimbic and Reduced Mesolimbic D-Impulsivity Associations in Parkinson's Disease.帕金森病患者边缘旁回和中边缘系统冲动控制的增强和减弱。
J Neurosci. 2023 Dec 13;43(50):8733-8743. doi: 10.1523/JNEUROSCI.1037-23.2023.
5
DRD2 expression based on F-fallypride PET/MR predicts the dopamine agonist resistance of prolactinomas: a pilot study.基于氟哌利多PET/MR的DRD2表达预测泌乳素瘤对多巴胺激动剂的耐药性:一项初步研究。
Endocrine. 2023 May;80(2):419-424. doi: 10.1007/s12020-023-03310-0. Epub 2023 Jan 23.
6
Dopamine D3 Receptor in Parkinson Disease: A Prognosis Biomarker and an Intervention Target.帕金森病中的多巴胺 D3 受体:一个预后生物标志物和干预靶点。
Curr Top Behav Neurosci. 2023;60:89-107. doi: 10.1007/7854_2022_373.
7
Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis.精神分裂症患者丘脑多巴胺 D2 受体可利用性:一项针对首发精神病且未经抗精神病药物治疗的患者的研究及荟萃分析。
Mol Psychiatry. 2022 Feb;27(2):1233-1240. doi: 10.1038/s41380-021-01349-x. Epub 2021 Nov 10.
8
Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia.多巴胺 D1 受体刺激作为精神分裂症的一种潜在认知目标机制。
Schizophr Bull. 2022 Jan 21;48(1):199-210. doi: 10.1093/schbul/sbab095.
9
Thalamic Nuclei Volumes in Psychotic Disorders and in Youths With Psychosis Spectrum Symptoms.丘脑核体积在精神病性障碍及有精神病谱系症状的青少年中的变化。
Am J Psychiatry. 2020 Dec 1;177(12):1159-1167. doi: 10.1176/appi.ajp.2020.19101099. Epub 2020 Sep 11.
10
The Pharmacology of Visual Hallucinations in Synucleinopathies.突触核蛋白病中视幻觉的药理学
Front Pharmacol. 2019 Dec 9;10:1379. doi: 10.3389/fphar.2019.01379. eCollection 2019.
使用[18F]法利哌啶正电子发射断层扫描技术对人类纹状体和纹状体以外区域的基线多巴胺D2受体占有率进行评估。
Biol Psychiatry. 2008 Jan 15;63(2):241-4. doi: 10.1016/j.biopsych.2007.03.022. Epub 2007 Jun 27.
4
Midbrain dopamine D2/3 receptor binding in schizophrenia.精神分裂症中脑多巴胺D2/3受体结合情况
Eur Arch Psychiatry Clin Neurosci. 2006 Sep;256(6):382-7. doi: 10.1007/s00406-006-0649-3. Epub 2006 Jun 16.
5
Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine.氯氮平和喹硫平对纹状体及纹状体以外多巴胺D2受体的占有率。
Neuropsychopharmacology. 2006 Sep;31(9):1991-2001. doi: 10.1038/sj.npp.1301108. Epub 2006 May 31.
6
D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia.精神分裂症患者丘脑和皮质中[F-18]氟哌利多与D2/D3多巴胺受体的结合情况。
Schizophr Res. 2006 Jul;85(1-3):232-44. doi: 10.1016/j.schres.2006.03.042. Epub 2006 May 19.
7
Frontal dopamine D(2/3) receptor binding in drug-naive first-episode schizophrenic patients correlates with positive psychotic symptoms and gender.初发未用药的精神分裂症患者的额叶多巴胺D(2/3)受体结合与阳性精神病性症状及性别相关。
Biol Psychiatry. 2006 Sep 15;60(6):621-9. doi: 10.1016/j.biopsych.2006.01.010. Epub 2006 Apr 3.
8
Cognitive development in schizophrenia: follow-back from the first episode.精神分裂症的认知发展:首次发作后的追溯研究
J Clin Exp Neuropsychol. 2006 Feb;28(2):270-82. doi: 10.1080/13803390500360554.
9
Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans.苯丙胺引起的人体纹状体和纹状体以外区域中[18F]法氯必利的取代。
Neuropsychopharmacology. 2006 May;31(5):1016-26. doi: 10.1038/sj.npp.1300916.
10
The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.氯氮平在精神分裂症患者中的纹状体和纹状体以外区域D2/D3受体结合情况
Neuropsychopharmacology. 2006 May;31(5):1027-35. doi: 10.1038/sj.npp.1300931.